Transvenous versus subcutaneous implantable cardiac defibrillators for people at risk of sudden cardiac death
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transvenous Versus Subcutaneous Implantable Cardiac Defibrillators for People at Risk of Sudden Cardiac Death." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433216/all/Botulinum_toxin_type_A_therapy_for_cervical_dystonia_Edited__no_change_to_conclusions_. Accessed 24 April 2024.
Transvenous versus subcutaneous implantable cardiac defibrillators for people at risk of sudden cardiac death. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433216/all/Botulinum_toxin_type_A_therapy_for_cervical_dystonia_Edited__no_change_to_conclusions_. Accessed April 24, 2024.
Transvenous versus subcutaneous implantable cardiac defibrillators for people at risk of sudden cardiac death. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433216/all/Botulinum_toxin_type_A_therapy_for_cervical_dystonia_Edited__no_change_to_conclusions_
Transvenous Versus Subcutaneous Implantable Cardiac Defibrillators for People at Risk of Sudden Cardiac Death [Internet]. In: Cochrane Abstracts. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433216/all/Botulinum_toxin_type_A_therapy_for_cervical_dystonia_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transvenous versus subcutaneous implantable cardiac defibrillators for people at risk of sudden cardiac death
ID - 433216
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433216/all/Botulinum_toxin_type_A_therapy_for_cervical_dystonia_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -